Remembering J. Craig Venter, PhD

About this episode

The episode reflects on the life and contributions of J. Craig Venter, PhD, following his passing.

Craig Venter recently passed away at the age of 79 from complications following a cancer diagnosis. He was well known in both science and industry and was an integral part of sequencing the human genome in the late 90s, competing with the government organized Human Genome Project. Through his career, he made many other important contributions in microbiology, with the “minimal cell”, in synthetic biology, and in personalized medicine. GEN editors share anecdotes of their experiences with him, reflect on the impact that his work has had on various fields in biology, in biotech, and in how the world has responded to the disruptions caused by Venter.   Join GEN editors Corinna Singleman, PhD, John Sterling, Kevin Davies, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.    Listed below are links to the GEN stories referenced in this episode of Touching Base :  Genomics Pioneer and Life Sciences Entrepreneur J. Craig Venter Dies at 79 GEN , April 30, 2026   J. Craig Venter Describes a Human Genomics Revolution Still In Progress By J. Craig Venter, PhD, GEN , June 13, 2025   Lessons from the Minimal Cell By Hana El-Samad…

People in this episode

Host: Corinna Singleman, PhD

Guests: John Sterling, Kevin Davies, PhD, Uduak Thomas

Topics covered

• J. Craig Venter
• human genome
• biotechnology
• microbiology
• personalized medicine
• biopharma news

Keywords

• J. Craig Venter
• human genome
• biotechnology
• microbiology
• personalized medicine
• biopharma
• GEN

Mentioned in this episode

Organizations: Genetic Engineering & Biotechnology News

More episodes of Touching Base

• A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News · June 4, 2026 · 37 min
• AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships · May 22, 2026 · 32 min
• AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains · April 23, 2026 · 33 min
• Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge · April 9, 2026 · 32 min
• Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers · March 26, 2026 · 40 min
• Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster · March 13, 2026 · 41 min